Cargando…

Oncological Outcome of Primary and Secondary Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-analysis

Conflicting results of survival outcomes for primary and secondary muscle-invasive bladder cancer (MIBC) have been reported in previous studies. Primary MIBC is defined as presentation of muscle-invasive disease at initial diagnosis while secondary MIBC presumes that non-muscle invasive disease late...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ge, Peng, Wang, Li, Lu, Meng, Mao, Lijun, Li, Wang, Wen, Rumin, Lin, Jian, Wang, Junqi, Chen, Jiacun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954122/ https://www.ncbi.nlm.nih.gov/pubmed/29765120 http://dx.doi.org/10.1038/s41598-018-26002-6

Ejemplares similares

SATB1 is overexpressed in metastatic prostate cancer and promotes prostate cancer cell growth and invasion
por: Mao, Lijun, et al.
Publicado: (2013)

How to Perform Intravesical Chemotherapy after Second TURBT for Non-Muscle-Invasive Bladder Cancer: A Single-Center Experience
por: Li, Zhen, et al.
Publicado: (2022)

Comparison of survival outcomes between primary and secondary muscle-invasive bladder cancer: An updated meta-analysis
por: Zheng, Xiaonan, et al.
Publicado: (2021)

Is there an oncological benefit to extended lymphadenectomy for muscle-invasive bladder cancer?
por: Clinton, Timothy N., et al.
Publicado: (2020)

The natural history of secondary muscle-invasive bladder cancer
por: Hidas, Guy, et al.
Publicado: (2013)

The Impact of Primary Versus Secondary Muscle-invasive Bladder Cancer at Diagnosis on the Response to Neoadjuvant Chemotherapy
por: D'Andrea, David, et al.
Publicado: (2022)

A novel signature constructed by differential genes of muscle-invasive and non-muscle-invasive bladder cancer for the prediction of prognosis in bladder cancer
por: Wang, Weizhuo, et al.
Publicado: (2023)

“Primary” and “secondary” muscle-invasive bladder cancer is more than just a surrogate for molecular subtypes
por: Pietzak, Eugene J., et al.
Publicado: (2019)

A meta-analysis of narrow band imaging for the diagnosis and therapeutic outcome of non-muscle invasive bladder cancer
por: Xiong, YiQuan, et al.
Publicado: (2017)

Preoperative Systemic Inflammatory Markers as a Significant Prognostic Factor After TURBT in Patients with Non-Muscle-Invasive Bladder Cancer
por: Ding, Li, et al.
Publicado: (2023)

Oncological effectiveness of bladder-preserving trimodal therapy versus radical cystectomy for the treatment of muscle-invasive bladder cancer: a system review and meta-analysis
por: Su, Xiaozhe, et al.
Publicado: (2023)

Collagen stiffness promoted non-muscle-invasive bladder cancer progression to muscle-invasive bladder cancer
por: Zhu, Huier, et al.
Publicado: (2019)

A New Tool for Distinguishing Muscle Invasive and Non-Muscle Invasive Bladder Cancer: The Initial Application of Flexible Ultrasound Bronchoscope in Bladder Tumor Staging
por: Xu, Chuanliang, et al.
Publicado: (2014)

Neoadjuvant cisplatin-based chemotherapy in “primary” and “secondary” muscle-invasive bladder cancer—is it a surrogate for molecular subtypes?
por: Szarvas, Tibor, et al.
Publicado: (2019)

Development and external validation of a novel nomogram model for predicting postoperative recurrence-free survival in non-muscle-invasive bladder cancer
por: Ding, Li, et al.
Publicado: (2022)

Oncological and prognostic impact of lymphovascular invasion in Colorectal Cancer patients
por: Wang, Xiaofei, et al.
Publicado: (2021)

Low expression of protocadherin7 (PCDH7) is a potential prognostic biomarker for primary non-muscle invasive bladder cancer
por: Lin, Ying-Li, et al.
Publicado: (2016)

Oncologic outcomes of Bacillus Calmette-Guérin therapy in elderly patients with non-muscle-invasive bladder cancer: A meta-analysis
por: Aghamir, Seyed Mohammad Kazem, et al.
Publicado: (2022)

Muscle invasive urinary bladder urothelial carcinoma presenting with secondary nephrotic symptoms
por: Mizusawa, Hiroya, et al.
Publicado: (2021)

Oncological Outcomes of Sequential Intravesical Gemcitabine and Docetaxel in Patients with Non-Muscle Invasive Bladder Cancer
por: Milbar, Niv, et al.
Publicado: (2017)

Oncological outcomes of high-grade T1 non-muscle-invasive bladder cancer treatment in octogenarians
por: Ślusarczyk, Aleksander, et al.
Publicado: (2021)

Comparison of the survival outcomes between primary and secondary muscle-invasive bladder cancer: a propensity score-matched study
por: Lok, Waichan, et al.
Publicado: (2023)

Identification of prognostic biomarkers associated with stromal cell infiltration in muscle‐invasive bladder cancer by bioinformatics analyses
por: Li, Pan, et al.
Publicado: (2020)

Differential Prognosis and Response of Denovo vs. Secondary Muscle-Invasive Bladder Cancer: An Updated Systematic Review and Meta-Analysis
por: Pones, Mario, et al.
Publicado: (2021)

Bladder Preservation for Muscle Invasive Bladder Cancer
por: Mirza, Arafat, et al.
Publicado: (2016)

The Hierarchy of Protoxylem Groupings in Primary Root and Their Plasticity to Nitrogen Addition in Three Tree Species
por: Li, Zhongyue, et al.
Publicado: (2022)

Secondary neoplasms of the urinary bladder-clinical management and oncological outcomes
por: El-Taji, Omar, et al.
Publicado: (2021)

Bladder-sparing approaches for muscle invasive bladder cancer: a narrative review of current evidence and future perspectives
por: Fan, Xinxiang, et al.
Publicado: (2023)

Biomarkers for the prediction of oncologic outcomes in non-muscle invasive bladder cancer: state of affairs and new frontiers
por: Soria, Francesco, et al.
Publicado: (2018)

Association of De Ritis ratio with oncological outcomes in patients with non-muscle invasive bladder cancer (NMIBC)
por: Laukhtina, Ekaterina, et al.
Publicado: (2020)

The Impact of Histological Variants on Oncological Outcomes in Patients with Muscle Invasive Bladder Cancer Treated with Radical Cystectomy
por: Efiloğlu, Özgür, et al.
Publicado: (2023)

Corrigendum: The hierarchy of protoxylem groupings in primary root and their plasticity to nitrogen addition in three tree species
por: Li, Zhongyue, et al.
Publicado: (2023)

AB007. Bladder-sparing treatments for muscle-invasive bladder cancer
por: Li, Shengwen, et al.
Publicado: (2017)

Meta-analysis of microRNAs as biomarkers for muscle-invasive bladder cancer
por: Zheng, Lin-Feng, et al.
Publicado: (2016)

Bladder Sparing Approaches for Muscle-Invasive Bladder Cancers
por: El-Taji, Omar M. S., et al.
Publicado: (2016)

Comparative Outcomes of Primary Versus Recurrent High-risk Non–muscle-invasive and Primary Versus Secondary Muscle-invasive Bladder Cancer After Radical Cystectomy: Results from a Retrospective Multicenter Study
por: Grossmann, Nico C., et al.
Publicado: (2022)

Trends in neoadjuvant chemotherapy use and oncological outcomes for muscle-invasive bladder cancer in Japan: a multicenter study
por: Anan, Go, et al.
Publicado: (2017)

Oncological outcomes, quality of life outcomes and complications of partial cystectomy for selected cases of muscle-invasive bladder cancer
por: Ebbing, Jan, et al.
Publicado: (2018)

Predictors of Outcome of Non–Muscle-Invasive and Muscle-Invasive Bladder Cancer
por: Youssef, Ramy F., et al.
Publicado: (2011)

Prognostic value of T1 substaging on oncological outcomes in patients with non-muscle-invasive bladder urothelial carcinoma: a systematic literature review and meta-analysis
por: Kardoust Parizi, Mehdi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_pcauj7d39ahdgdfj1cvbnu84i6